Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease
Global Journal of Medical Research June 28, 2025 Norman W. Barton
Parkinson’s Disease (PD) is a progressive neurodegenerative disorder marked by motor symptoms due to dopaminergic degeneration and non-motor symptoms such as depression, anxiety, and cognitive impairment, which significantly affect patients' quality of life. Traditional dopaminergic therapies address motor symptoms but offer limited efficacy for neuropsychiatric manifestations. Psilocybin, a...
DOI: 10.34257/gjmravol25is1pg1 (opens in new tab)
Psilocybin
Parkinson's disease
Hallucinogen